Compare RTO & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RTO | HOLX |
|---|---|---|
| Founded | 1925 | 1985 |
| Country | United Kingdom | United States |
| Employees | 65632 | N/A |
| Industry | Business Services | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 16.6B |
| IPO Year | N/A | 1995 |
| Metric | RTO | HOLX |
|---|---|---|
| Price | $33.24 | $75.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 13 |
| Target Price | $35.00 | ★ $77.89 |
| AVG Volume (30 Days) | 1.5M | ★ 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $17.39 | $4.74 |
| Revenue Next Year | $6.25 | $5.03 |
| P/E Ratio | $222.16 | ★ $95.46 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $19.60 | $51.90 |
| 52 Week High | $33.46 | $75.75 |
| Indicator | RTO | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 60.34 | 53.87 |
| Support Level | $30.95 | $75.20 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.60 | 0.19 |
| MACD | 0.20 | -0.01 |
| Stochastic Oscillator | 95.91 | 37.27 |
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.